Current Projects

Role of maternal and infant vaccine-induced IgG in protection against pertussis
National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)- R21AI122248-01
Marcela F. Pasetti, PhD (PI)
01/01/15-12/31/19

Vaccines and Maternally Acquired Immunity to Prevent Shigellosis in Children
NIH/NIAID- 1R01AI117734-01
Marcela F. Pasetti, PhD (PI)
04/01/15-03/31/20

Immunogenicity of Double Mutant Heat-Labile Toxin (dmLT) from Escherichia coli Administered Intradermally (ID) to Healthy Adults
NIH/NIAID- HHSN272201300022I
Karen Kotloff, MD (PI)
Marcela F. Pasetti, PhD (Task Area D PI)
08/01/15-06/30/20

Serological Assays to Predict Shigella Vaccine Efficacy
NIH/NIAID- 1R01AI125841
Marcela F. Pasetti, PhD (PI)
04/22/16-0/21/21

Pathogenesis of E. coli and Shigella in Human Enteroid Models
NIH/NIAID- P01 AI 125181
James Kaper, PhD (PI) Marcela F. Pasetti, PhD (Immunology Core PI)
07/01/16-06/30/21

 

 

Pasetti Lab 6_2018_9568

Vaccine and Treatment Evaluation Unit (VTEU)
NIH/NIAID- HHSN272201300022I
Karen L. Kotloff, MD (PI) Marcela F. Pasetti, PhD (Co-Investigator)
09/06/13-09/15/23

VaxArt Norovirus “Bivalent” Study- 2019
VaxArt- 10621
Marcela F. Pasetti, PhD (PI)
07/01/19-02/29/20

Peptide Immunogenicity
Molecular Express Inc.
Marcela F. Pasetti, PhD (PI)
07/01/19-06/30/20